Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Gerber, MD
RTOG Foundation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Stanford University
Stanford, California, United States
- University of Florida
Gainesville, Florida, United States
- Mount Sinai Cancer Research Center
Miami Beach, Florida, United States
- Nancy N. & J.C. Lewis Cancer & Research Pavilion at St. Joseph'S/candler Hospital
Savannah, Georgia, United States
- University of Kentucky
Lexington, Kentucky, United States
- Mercy Medical Cancer Center
Baltimore, Maryland, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- Metro Health Medical Center
Cleveland, Ohio, United States
- Reading Hospital/mcglinn Cancer Institute
West Reading, Pennsylvania, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Inova Fairfax Hospital
Falls Church, Virginia, United States
- Virginia Mason
Seattle, Washington, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Oct 2016
- Primary completion
- 23 Jan 2019
- Completion
- 23 Jan 2019
- Last update posted
- 2 Jun 2021
- Registered enrollment
- 20
- Registry id
- NCT02768558
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.